Migraine treatment in pregnancy with a nerve stimulation device
Part of Brain & nervous system, Mental health, Pain clinical trials.
This trial tests if a device that gently stimulates a nerve on your forehead can safely treat migraines during pregnancy. You'll use the device at home and track your headaches via text or email.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 44 years old.
- You are pregnant with one baby (singleton pregnancy).
- You had migraines or headaches before pregnancy and they continue, or they started in your first trimester.
- You can provide proof of pregnancy (like an ultrasound report or a signed note from your doctor).
- You have access to a smartphone or computer with email or texting.
- You are willing and able to give simple consent to join the registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a temporary nerve-stimulation device placed near the back of your head to treat chronic headaches. The device sends mild electrical pulses to help reduce headache pain over 60 days, and your doctor has already decided this treatment is right for you as part of your regular care.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This study tests whether using a small device on the arm that sends gentle electrical pulses (called neuromodulation) can prevent disabling migraine attacks in young people when early warning signs appear. If it works, this could reduce the number of migraine days.
This trial tests a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) that uses magnetic pulses to stimulate the brain, aiming to reduce migraine pain. It is for people with frequent or chronic migraines who have not found relief from at least three preventive medications.
This study uses a safe, non-invasive technique called transcranial magnetic stimulation (TMS) to measure brain activity in people with migraine compared to healthy volunteers. It aims to understand how the brain's electrical signals differ in migraine, which could lead to better treatments.
This study tests a non-drug treatment called repetitive transcranial magnetic stimulation (rTMS) that uses magnetic pulses to gently stimulate the brain. It aims to reduce migraine frequency by personalizing the treatment to each person's brain. If you have frequent migraines, this could offer a new option without daily pills.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.